These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 39078863)
1. Correction: Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data. Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA PLoS One; 2024; 19(7):e0308242. PubMed ID: 39078863 [TBL] [Abstract][Full Text] [Related]
2. Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data. Moustaqim-Barrette A; Papamihali K; Mamdani Z; Williams S; Buxton JA PLoS One; 2020; 15(9):e0238618. PubMed ID: 32915834 [TBL] [Abstract][Full Text] [Related]
3. Factors associated with take-home naloxone kit usage in British Columbia: an analysis of administrative data. Lei V; Ferguson M; Geiger R; Williams S; Liu L; Buxton JA Subst Abuse Treat Prev Policy; 2022 Mar; 17(1):25. PubMed ID: 35361228 [TBL] [Abstract][Full Text] [Related]
4. Correction: Hospitalizations due to unintentional transport injuries among Aboriginal population of British Columbia, Canada: Incidence, changes over time and ecological analysis of risk markers. Brussoni M; George MA; Jin A; Amram O; McCormick R; Lalonde CE PLoS One; 2018; 13(2):e0193218. PubMed ID: 29447270 [TBL] [Abstract][Full Text] [Related]
5. Qualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia. Deonarine A; Amlani A; Ambrose G; Buxton JA Harm Reduct J; 2016 May; 13(1):17. PubMed ID: 27206486 [TBL] [Abstract][Full Text] [Related]
6. Correction: The effect of exposure to farmed salmon on piscine orthoreovirus infection and fitness in wild Pacific salmon in British Columbia, Canada. Morton A; Routledge R; Hrushowy S; Kibenge M; Kibenge F PLoS One; 2021; 16(3):e0248912. PubMed ID: 33725019 [TBL] [Abstract][Full Text] [Related]
7. Correction: The effect of exposure to farmed salmon on piscine orthoreovirus infection and fitness in wild Pacific salmon in British Columbia, Canada. Morton A; Routledge R; Hrushowy S; Kibenge M; Kibenge F PLoS One; 2023; 18(3):e0282687. PubMed ID: 36862722 [TBL] [Abstract][Full Text] [Related]
9. Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada. Guerra-Alejos BC; Yan Y; Kurz M; Mudalige N; Min JE; Homayra F; Nosyk B Addiction; 2024 Aug; 119(8):1453-1459. PubMed ID: 38584294 [TBL] [Abstract][Full Text] [Related]
10. The implementation and role of a staff naloxone program for non-profit community-based sites in British Columbia: A descriptive study. Williams S; King T; Papamihali K; Buxton JA PLoS One; 2021; 16(5):e0251112. PubMed ID: 33983996 [TBL] [Abstract][Full Text] [Related]
11. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: Findings from the Take Home Naloxone program. Karamouzian M; Kuo M; Crabtree A; Buxton JA Int J Drug Policy; 2019 Sep; 71():157-163. PubMed ID: 30691944 [TBL] [Abstract][Full Text] [Related]
12. Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study. Moustaqim-Barrette A; Papamihali K; Williams S; Ferguson M; Moe J; Purssell R; Buxton JA PLoS One; 2021; 16(10):e0259126. PubMed ID: 34714854 [TBL] [Abstract][Full Text] [Related]
13. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. Banjo O; Tzemis D; Al-Qutub D; Amlani A; Kesselring S; Buxton JA CMAJ Open; 2014 Jul; 2(3):E153-61. PubMed ID: 25295235 [TBL] [Abstract][Full Text] [Related]
14. Correction: Higher naloxone dosing in a quantitative systems pharmacology model that predicts naloxone-fentanyl competition at the opioid mu receptor level. PLOS ONE Staff PLoS One; 2020; 15(9):e0240148. PubMed ID: 32991627 [TBL] [Abstract][Full Text] [Related]
15. Cross-provincial use of cardiac services: the importance of data-sharing for clinical registries and outcomes research. Humphries KH; Carere RG; Izadnegahdar M; Galbraith PD; Knudtson ML; Ghali WA Can J Cardiol; 2005 Mar; 21(3):267-72. PubMed ID: 15776116 [TBL] [Abstract][Full Text] [Related]
16. Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis. Moustaqim-Barrette A; Papamihali K; Crabtree A; Graham B; Karamouzian M; Buxton JA Drug Alcohol Depend; 2019 Dec; 205():107609. PubMed ID: 31654839 [TBL] [Abstract][Full Text] [Related]
17. Access to naloxone at community pharmacies under the Massachusetts statewide standing order. Wu C; Brown T; Moreno JL J Am Pharm Assoc (2003); 2020; 60(4):647-652. PubMed ID: 31843374 [TBL] [Abstract][Full Text] [Related]
18. What Is Known about Community Pharmacy-Based Take-Home Naloxone Programs and Program Interventions? A Scoping Review. Cid A; Daskalakis G; Grindrod K; Beazely MA Pharmacy (Basel); 2021 Feb; 9(1):. PubMed ID: 33540676 [TBL] [Abstract][Full Text] [Related]
19. Correction: Precision public health: Mapping socioeconomic disparities in opioid dispensations at Swedish pharmacies by Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA). Persmark A; Wemrell M; Zettermark S; Leckie G; Subramanian SV; Merlo J PLoS One; 2019; 14(10):e0224008. PubMed ID: 31600326 [TBL] [Abstract][Full Text] [Related]